LEADER 01204nam0 22002893i 450 001 VAN0129360 005 20200605012851.585 010 $a978-88-916346-1-0 100 $a20200605d2019 |0itac50 ba 101 $aita 102 $aIT 105 $a|||| ||||| 200 1 $aConsorzi e società consortili$eguida pratica e formulario$eaggiornato con tutte le novità 2019$fCinzia De Stefanis, Antonio Quercia 205 $a3. ed 210 $aSantarcangelo di Romagna$cMaggioli$d2019 215 $a321 p.$d24 cm$e1 carta 410 1$1001VAN0001316$12001 $aProfessionisti & imprese$1210 $aSantarcangelo di Romagna$cMaggioli$v83 620 $dSantarcangelo di Romagna$3VANL000123 700 1$aDe Stefanis$bCinzia$3VANV017207$0267953 701 1$aQuercia$bAntonio$3VANV101551$0524401 712 $aMaggioli $3VANV108045$4650 801 $aIT$bSOL$c20240223$gRICA 899 $aBIBLIOTECA DEL DIPARTIMENTO DI ECONOMIA$1IT-CE0106$2VAN03 912 $aVAN0129360 950 $aBIBLIOTECA DEL DIPARTIMENTO DI ECONOMIA$d03PREST IVCd134 $e03BDE2133 20200605 996 $aConsorzi e società consortili$91745071 997 $aUNICAMPANIA LEADER 02477nam0 2200517 i 450 001 VAN0115413 005 20220316024403.784 017 70$2N$a978-3-319-28095-0 100 $a20180308d2016 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aSystem engineering approach to planning anticancer therapies$fAndrzej Swierniak ... [et al.] 210 $a[Cham]$cSpringer$d2016 215 $aIX, 235 p.$cill.$d24 cm 500 1$3VAN0243215$aSystem engineering approach to planning anticancer therapies$91523670 606 $a37N25$xDynamical systems in biology [MSC 2020]$3VANC020364$2MF 606 $a93Cxx$xModel systems in control theory [MSC 2020]$3VANC022769$2MF 606 $a92D25$xPopulation dynamics (general) [MSC 2020]$3VANC022805$2MF 606 $a93B35$xSensitivity (robustness) [MSC 2020]$3VANC022855$2MF 606 $a93-10$xMathematical modeling or simulation for problems pertaining to systems and control theory [MSC 2020]$3VANC025288$2MF 606 $a92C50$xMedical applications (general) [MSC 2020]$3VANC027825$2MF 606 $a92C42$xSystems biology, networks [MSC 2020]$3VANC029020$2MF 606 $a35Q92$xPDEs in connection with biology, chemistry and other natural sciences [MSC 2020]$3VANC031096$2MF 606 $a49N90$xApplications of optimal control and differential games [MSC 2020]$3VANC033550$2MF 610 $aAntibacterial drug resistance$9KW:K 610 $aAnticancer therapies$9KW:K 610 $aBiomathematical modelling$9KW:K 610 $aCell Cycle Analysis$9KW:K 610 $aCell cycle$9KW:K 610 $aDrug resistance$9KW:K 610 $aOptimimzation$9KW:K 610 $aPopulation dynamics$9KW:K 610 $aSignalling pathway dynamics$9KW:K 610 $aStructure models$9KW:K 620 $aCH$dCham$3VANL001889 702 1$aSwierniak$bAndrzej$3VANV089332 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240614$gRICA 856 4 $uhttp://dx.doi.org/10.1007/978-3-319-28095-0$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN0115413 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 2537 $e15EB 2537 20180308 996 $aSystem engineering approach to planning anticancer therapies$91523670 997 $aUNICAMPANIA